Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Medtronic

Stock Index Futures Muted as Focus Turns to Retail Earnings, U.S. Housing Data Awaited

September S&P 500 E-Mini futures (ESU25) are down -0.09%, and September Nasdaq 100 E-Mini futures (NQU25) are down -0.08% this morning as earnings from the nation’s retail heavyweights kicked off, shifting the focus to the strength of the American consumer.

Barchart

Medtronic Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Medtronic plc (NYSE:MDT) will release financial results for the first quarter before the opening bell on Tuesday, Aug. 19.

Benzinga

Are Wall Street Analysts Bullish on Medtronic Stock?

While Medtronic has struggled to keep up with the broader market over the past year, analysts remain fairly upbeat on its future growth prospects.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Here's What to Expect From Medtronic's Next Earnings Report

Medtronic is all set to release its fiscal first-quarter earnings later next month, and analysts project earnings in line with the year-ago quarter.

Barchart

Court Nixes Jury Award Over Medtronic's Heart Valve Infringement Claim

A federal appeals court has sided with Medtronic Plc (NYSE:MDT) in a long-running patent dispute, reversing a jury's finding that the company induced infringement of a Colibri Heart Valve LLC patent related to the implantation of artificial heart valves.

Benzinga

5 Robotics Stocks to Buy for the Future of Automation

Robotics adoption is accelerating globally, with AI, automation, and real-time data processing reshaping industries from healthcare to manufacturing.

MarketBeat

Medtronic Stock Is Climbing Friday: What's Going On?

On Wednesday, the Centers for Medicare Medicaid Services (CMS) proposed a significant step toward broader adoption of renal denervation (RDN) by offering coverage for both radiofrequency (rfRDN) and ultrasound (uRDN) technologies for uncontrolled hypertension. This coverage would be granted under a Coverage with Evidence Development (CED) framework, requiring treatment within…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Cathie Wood Vs. Jim Cramer: TV Host Says Top Ark AI Pick 'Losing Money Hand Over Fist'

When it comes to artificial intelligence stocks, there are multiple that are found in the various portfolios of Ark Funds, led by Cathie Wood.

Benzinga

This $125M Israeli Startup Is Building The World's First Cataract Robot To Solve A Global Crisis: 'There Is No Human Way To Close The Gap'

ForSight Robotics, an Israeli startup aiming to automate cataract and eye surgery, announced Tuesday that it raised $125 million to expand its precision robotics platform, Oryom.

Benzinga

3 Safe Buy-and-Hold Dividend Stocks With Strong Balance Sheets

These 3 dividend stocks offer strong balance sheets, low debt, and reliable payouts, making them solid long-term picks for income investors

MarketBeat

3 Stocks With 3% to 9% Yields Just Raised Dividends Again

See these stocks with hefty dividend yields that just boosted payouts further. One has a yield closing in on 10%, with even more upside potential per analysts.

MarketBeat

Why the Death Cross Could Be a Contrarian Signal for Medtronic (MDT)

Although MDT stock is about to flash an ominous technical indicator, quantitative-focused investors will want to keep Medtronic on their watch list.

Barchart

What Are Wall Street Analysts’ Target Price for Medtronic Stock?

While Medtronic has underperformed relative to the broader market over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Barchart

Medtronic: A Dividend Aristocrat With Stability and Innovation

Medtronic delivers consistent dividend growth and healthcare innovation, positioning it as a stable investment choice in today's dynamic market environment.

MarketBeat

Get all your
news in one place.

100’s of premium titles.
One news app.

Kiplinger

Want to Live Longer? Here's What Works

With longevity science booming, you might make it to age 150. We separate the hype from proven strategies. Because the "science is extremely promising."

MarketBeat

Medtronic’s Expansion Gains Momentum—Time for a Market Shift?

Medtronic is on track to complete a market reversal later this year as investments in technology and innovation begin to pay off.

Fortune

Medtronic taps Renault's CFO to be its new finance chief. How his unusual career path helped land the job

Thierry Piéton will end his CFO tenure at French automaker Renault Group on Feb. 28.

Barchart

Medtronic's Quarterly Earnings Preview: What You Need to Know

Medtronic is poised to release its fiscal third-quarter earnings next month, and analysts project a single-digit profit growth.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Conversation

How we diagnose and define obesity is set to change – here’s why, and what it means for treatment

Obesity is linked to many common diseases, such as type 2 diabetes, heart disease, fatty liver disease and knee osteoarthritis.

MarketBeat

3 Stocks Helping to Bring AI to Healthcare

Many profitable companies are using AI to make healthcare more efficient; and these companies are rewarding investors with share price growth and dividends

MarketBeat

2 Robotic Surgery Stocks Challenging Intuitive Surgical's Lead

Medtronic (MDT) and Zimmer Biomet (ZBH) are emerging as serious contenders in robotic surgery, challenging Intuitive Surgical’s (ISRG) market dominance.

StockNews.com

3 MedTech Innovators Revolutionizing Patient Care

The medtech market is thriving, thanks to the increasing investments and surging demand for enhanced efficiency. Therefore, investors could benefit from these trends by investing in fundamentally solid medical device stocks Becton, Dickinson and Company (BDX), Medtronic (MDT), and Abbott Laboratories (ABT), which are revolutionizing patient care. Keep reading.

Barchart

Is Medtronic Stock Underperforming the S&P 500?

Although Medtronic has lagged behind the broader S&P 500 index over the past three months, analysts remain moderately optimistic about the stock’s prospects.

MarketBeat

5 Dividend Aristocrats to Buy Now and Hold Through 2025

The Dividend Aristocrats offer reliable yields; buying them when they are down provides a lever for total returns and a vehicle for market-beating returns.

MarketBeat

Medtronic: A Dividend Aristocrat Powering Up for 2025 and Beyond

Medtronic's stock price is in a classic head-and-shoulders reversal that could take it back to record highs within the next two years.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.